Some of the most important med schools and academic medical centers do not comply with their commitments to reduce the impact on the public of the pharmaceutical industry on their faculties.
Our friends in the way of their database ProPublica companies drug disclosures in order to verify the school performance and disabled for quite a few infringements.
Stanford, which deal with big a few years ago, of the prohibition, speaking gigs paid by drugmakers had several scofflaws visibility. For example, Dr. Alan Yeung, Vice President of the Stanford by the Faculty of medicine and the main cardiovascular medicine obtained $ 53,000 from Eli Lilly last year and in the first half of 2010. Psychiatrist children and Professor Emeritus Hans Steiner was paid $ 109,000 by Lilly, too.
The primary problem for those speaking gigs is the control of the company. ProPublica rounds up policy discussions and drugmakers require experts of company prepared materials. ProPublica also, that the problems at the University of Pittsburgh, University of Pennsylvania and University of Colorado, Denver.
The future of the story's Stanford Medical ProPublica, Dean Dr. Philip Pizzo sent from another warning Department:
I am fully aware that we have witnessed the change in the relationship between academia and industry, and the related conflict of interests will take to distribution, and also lead to changes in behavior and activity. But ... There are many from the earlier communication policy in Stanford and multiple threads in the layout and the medical press about problems with doctors perform marketing roles. This is unacceptable, certainly for anyone who has a title of Stanford.
Stanford also have dinged earlier this year for the grant of Pfizer 3 million dollars to improve doctor training, transfer, that Dr. Adriane Fugh-Berman, who runs PharmedOut project, called "self-satirizing" in time.
No comments:
Post a Comment